Modal DNA Values and Estramustine-Binding Protein (EMBP) as Prognostic Markers in Prostatic Cancer

Authors

  • H. Nordgren DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • S. Nilsson DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • S. Eklöv DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • P. Stattin DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • W. Naining DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • T. Heiden DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • L. Bergkvist DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • L. Karlberg DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • C. Lundholm DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • B. Harvig DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • P. Strang DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • R. Bergström DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN
  • B. Tribukait DEPARTMENTS OF CLINICAL PATHOLOGY UROLOGY, AND SURGERY, CENTRAL HOSPITAL, VÄSTERÅS; THE DEPARTMENT OF ONCOLOGY AKADEMISKA HOSPITAL, UNIVERSITY OF UPPSALA, UPPSALA; THE DEPARTMENT OF MEDICAL RADIATION BIOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM; THE DEPARTMENT OF STATISTICS, UNIVERSITY OF UPPSALA, UPPSALA, SWEDEN

DOI:

https://doi.org/10.3109/02841869109092353

Keywords:

Prostatic cancer, estramustine-binding protein, EMBP, DNA, flow cytometry, prognostic marker

Abstract

In this study, we have investigated the modal DNA values and the expression of estramustine-binding protein (EMBP) in formalin-fixed and paraffin-embedded TUR specimens from 76 untreated patients with prostatic cancer. in addition, specimens from 13 patients were analyzed for tumour EMBP expression only. Ploidy was measured as diploid, tetraploid and non-tetraploid aneuploid or aneuploid in the near-diploid region. All patients had been referred during 1978–1981, and were subjected to TUR due to urinary obstruction. Survival data were obtained for all patients through March 1988. Statistical analyses were performed using a Cox's regression model with respect to survival and cause specific survival and correlated to the DNA pattern and the expression of EMBP. the existence of a near-diploid aneuploid cell population as well as poor differentiation grade were both statistically significantly correlated with poor survival. Near-diploid aneuploid cell lines were seen in 9/76 (12%) of the patients and were also seen in well differentiated cancers (4/17). the expression of EMBP was most abundant in the moderately differentiated cancers. However, all prostatic cancer specimens investigated were positive for the antigen. Patients with poorly differentiated carcinomas and high EMBP expression showed a tendency towards better prognosis than those with poorly differentiated carcinomas and low EMBP expression. the present patient material was, however, too small to show a statistically significant correlation between EMBP and survival.

Downloads

Download data is not yet available.

Downloads

Published

1991-01-01

How to Cite

Nordgren, H., Nilsson, S., Eklöv, S., Stattin, P., Naining, W., Heiden, T., … Tribukait, B. (1991). Modal DNA Values and Estramustine-Binding Protein (EMBP) as Prognostic Markers in Prostatic Cancer. Acta Oncologica, 30(2), 211–214. https://doi.org/10.3109/02841869109092353

Issue

Vol. 30 No. 2 (1991): Acta Oncologica

Section

Articles